Table 1.
Antibody | Antigen/Epitope | Dilution | Source | Reference |
---|---|---|---|---|
6E10 | Aβ 6–10 | 1 μg/ml (ELISA) | Biolegend | Kim et al., 1988 |
4G8 | Aβ 18–22 | 1 μg/ml (ELISA) | Biolegend | Chang et al., 2007 |
266 | Aβ 13–28 | 3 μg/ml (MSD) | Janssen | Johnson-Wood et al., 1997 |
HJ2 | Ap terminating at Val40 | 1 μg/ml (WB) | D. Holtzman | Pankiewicz et al., 2014 |
21F12 | Aβ terminating at Ile42 | 1 μg/ml (WB) 1/8,000 (MSD) | Janssen | Johnson-Wood et al., 1997 |
IC22 | Aβ aggregates | 3 μg/ml (0.02 μM) (Neurotoxicity assay) | Walsh lab | Mably et al., 2015 |
MI0131 | PrP 23–51 | 1 μg/ml (WB) | Medimmune | Ondrejcak et al., 2018 |
6D11 | PrP 93–109 | 1 μg/ml (WB) | Biolegend | Pankiewicz et al., 2006 |
ICSM35 | PrP 95–105 | 5 μg/ml (IP) | J. Collinge | White et al., 2003 |